Nicholas W Carrellas1, Joseph Biederman2, Mai Uchida3. 1. Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA. 2. Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA. 3. Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA. Electronic address: muchida@partners.org.
Abstract
INTRODUCTION: Major Depressive Disorder (MDD) among youth is a public health concern. Our aim was to examine the current body of knowledge to better characterize the prevalence and morbidity associated with subthreshold forms of MDD among youth. Given that MDD tends to develop gradually over time, we hypothesized a high prevalence and considerable impairment associated with youth suffering from depressive symptoms that fall short of full, syndromic status. METHODS: A literature search was conducted using PubMed exclusively to identify studies assessing the prevalence and clinical characteristics of subthreshold MDD in adolescents. RESULTS: Six scientific papers that met our priori inclusion and exclusion criteria were identified. All papers sampled adolescents. The prevalence of subthreshold MDD ranged from 5% over the past year, to 29% over the two weeks prior to screening. These papers reported clinically significant morbidity associated with subthreshold MDD among adolescents, with evidence for elevated rates of psychiatric comorbidities, impaired functioning in social and familial domains, increased suicidality, and frequent mental health service utilization. LIMITATIONS: Though we examined a sizeable and diverse sample, we only identified six cross-sectional informative studies for this review. Variability of subthreshold MDD and major outcome definitions across studies, likely limits the specificity of findings. CONCLUSIONS: Subthreshold MDD is prevalent among youth, and is associated with emotional and social impairments that reach the level of obtaining clinical care. These findings could lead to early intervention efforts aimed at mitigating the adverse outcomes associated with subthreshold MDD as well as the progression to full syndrome MDD. Our review documents that regardless of whether progression to full diagnostic status occurs, this condition is morbid.
INTRODUCTION: Major Depressive Disorder (MDD) among youth is a public health concern. Our aim was to examine the current body of knowledge to better characterize the prevalence and morbidity associated with subthreshold forms of MDD among youth. Given that MDD tends to develop gradually over time, we hypothesized a high prevalence and considerable impairment associated with youth suffering from depressive symptoms that fall short of full, syndromic status. METHODS: A literature search was conducted using PubMed exclusively to identify studies assessing the prevalence and clinical characteristics of subthreshold MDD in adolescents. RESULTS: Six scientific papers that met our priori inclusion and exclusion criteria were identified. All papers sampled adolescents. The prevalence of subthreshold MDD ranged from 5% over the past year, to 29% over the two weeks prior to screening. These papers reported clinically significant morbidity associated with subthreshold MDD among adolescents, with evidence for elevated rates of psychiatric comorbidities, impaired functioning in social and familial domains, increased suicidality, and frequent mental health service utilization. LIMITATIONS: Though we examined a sizeable and diverse sample, we only identified six cross-sectional informative studies for this review. Variability of subthreshold MDD and major outcome definitions across studies, likely limits the specificity of findings. CONCLUSIONS: Subthreshold MDD is prevalent among youth, and is associated with emotional and social impairments that reach the level of obtaining clinical care. These findings could lead to early intervention efforts aimed at mitigating the adverse outcomes associated with subthreshold MDD as well as the progression to full syndrome MDD. Our review documents that regardless of whether progression to full diagnostic status occurs, this condition is morbid.
Authors: Clayton S Edwards; Caroline M Roberts; Marissa N Baudino; Nathan L Basile; Kaitlyn L Gamwell; Noel J Jacobs; Jeanne Tung; John E Grunow; Larry L Mullins; John M Chaney Journal: J Clin Psychol Med Settings Date: 2022-06-06
Authors: Denise H M Bodden; Marieke W H van den Heuvel; Rutger C M E Engels; Carmen D Dirksen Journal: J Child Psychol Psychiatry Date: 2021-09-08 Impact factor: 8.265
Authors: Sara N Rushia; Sophie Schiff; Dakota A Egglefield; Jeffrey N Motter; Alice Grinberg; Daniel G Saldana; Al Amira Safa Shehab; Jin Fan; Joel R Sneed Journal: J Psychiatr Brain Sci Date: 2020-06-19
Authors: Karlijn W J de Jonge-Heesen; Sanne P A Rasing; Ad A Vermulst; Ron H J Scholte; Kim M van Ettekoven; Rutger C M E Engels; Daan H M Creemers Journal: BMC Med Date: 2020-07-24 Impact factor: 8.775
Authors: Julia Philipp; Michael Zeiler; Karin Waldherr; Stefanie Truttmann; Wolfgang Dür; Andreas F K Karwautz; Gudrun Wagner Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-08-29 Impact factor: 4.328
Authors: Yasmina Nasstasia; Amanda L Baker; Sean A Halpin; Leanne Hides; Terry J Lewin; Brian J Kelly; Robin Callister Journal: Contemp Clin Trials Commun Date: 2017-11-24
Authors: Enrique Becerril-Villanueva; Gilberto Pérez-Sánchez; Samantha Alvarez-Herrera; Manuel Iván Girón-Pérez; Rodrigo Arreola; Carlos Cruz-Fuentes; Lino Palacios; Francisco R de la Peña; Lenin Pavón Journal: Mediators Inflamm Date: 2019-11-19 Impact factor: 4.711
Authors: Eva Langvik; Ingvild Saksvik-Lehouillier; Leif Edward Ottesen Kennair; Torhild Anita Sørengaard; Mons Bendixen Journal: Health Psychol Behav Med Date: 2019-05-15